DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News
I'm PortAI, I can summarize articles.
DaVita, a kidney care company, praised the Center for Medicare and Medicaid Innovation's (CMMI) decision to extend the Kidney Care Choices (KCC) Model for another year. Misha Palecek, DaVita's chief transformation officer, highlighted the program's focus on value-based care, which has led to improved health outcomes and increased patient engagement. DaVita has expanded its value-based care arrangements from 11 to 22 Kidney Contracting Entities (KCEs) since 2022, resulting in more transplants and better dialysis access for patients. DaVita aims to set a new standard in kidney care through integrated systems with nephrology partners.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments